Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_assertion type Assertion NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_head.
- NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_assertion description "[These include the hyperinsulinism/hyperammonemia syndrome caused by dominant activating mutations of GLUD1 which interfere with inhibitory regulation by GTP and hyperinsulinism due to recessive deficiency of short-chain 3-hydroxy-acyl-CoA dehydrogenase (SCHAD, encoded by HADH1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_provenance.
- NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_assertion evidence source_evidence_literature NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_provenance.
- NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_assertion SIO_000772 21130127 NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_provenance.
- NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_assertion wasDerivedFrom befree-2016 NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_provenance.
- NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_assertion wasGeneratedBy ECO_0000203 NP856893.RAfy_ZoBd_8oEzHgS2PJW15hj3K5s-fvywErSZ-5ojFys130_provenance.